European Journal of Cancer
Volume 41, Issue 17 , Pages 2655-2661, November 2005

Fulvestrant (‘Faslodex’) in pre-treated patients with advanced breast cancer: A single-centre experience

  • G.G. Steger

      Affiliations

    • Division of Oncology, Department of Internal Medicine I, Medical University of Vienna, 18–20 währinger Gürtel, A-1090 Vienna, Austria
    • Corresponding Author InformationCorresponding author. Tel.: +43 140 400 5466; fax: +43 140 400 6081.
    • ,
  • R. Bartsch

      Affiliations

    • Division of Oncology, Department of Internal Medicine I, Medical University of Vienna, 18–20 währinger Gürtel, A-1090 Vienna, Austria
    • ,
  • C. Wenzel

      Affiliations

    • Division of Oncology, Department of Internal Medicine I, Medical University of Vienna, 18–20 währinger Gürtel, A-1090 Vienna, Austria
    • ,
  • U. Pluschnig

      Affiliations

    • Division of Oncology, Department of Internal Medicine I, Medical University of Vienna, 18–20 währinger Gürtel, A-1090 Vienna, Austria
    • ,
  • D. Hussian

      Affiliations

    • Division of Oncology, Department of Internal Medicine I, Medical University of Vienna, 18–20 währinger Gürtel, A-1090 Vienna, Austria
    • ,
  • U. Sevelda

      Affiliations

    • Division of Oncology, Department of Internal Medicine I, Medical University of Vienna, 18–20 währinger Gürtel, A-1090 Vienna, Austria
    • ,
  • G.J. Locker

      Affiliations

    • Division of Oncology, Department of Internal Medicine I, Medical University of Vienna, 18–20 währinger Gürtel, A-1090 Vienna, Austria
    • ,
  • M.F. Gnant

      Affiliations

    • Department of Surgery, Medical University of Vienna, Vienna, Austria
    • ,
  • R. Jakesz

      Affiliations

    • Department of Surgery, Medical University of Vienna, Vienna, Austria
    • ,
  • C.C. Zielinski

      Affiliations

    • Division of Oncology, Department of Internal Medicine I, Medical University of Vienna, 18–20 währinger Gürtel, A-1090 Vienna, Austria

Received 15 March 2005; received in revised form 1 July 2005; accepted 7 July 2005.

Full Text Available

  • Purchase this article for  31.50 USD

    Access is available for 24 hours.

    (Login or Register to purchase)

  • Subscribe to this title
  • Claim access now

    Current subscribers


    • PII: S0959-8049(05)00725-2

    doi:10.1016/j.ejca.2005.07.016

    European Journal of Cancer
    Volume 41, Issue 17 , Pages 2655-2661, November 2005